TRV PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Trv Pharma Limited. The company was founded 11 years ago and was given the registration number 08963585. The firm's registered office is in GILLINGHAM. You can find them at 29 Academy Drive, , Gillingham, Kent. This company's SIC code is 47730 - Dispensing chemist in specialised stores.

Company Information

Name	:	TRV PHARMA LIMITED
Company Number	:	08963585
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active
Incorporation Date	:	27 March 2014
End of financial year	:	31 March 2024
Jurisdiction	:	England - Wales
Industry Codes	:	47730 - Dispensing chemist in specialised stores

Office Address & Contact

Registered Address	:	29 Academy Drive, Gillingham, Kent, ME7 3EG
Country Origin	:
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

Company Officers

Personal Information	Role	Appointed	Status
29 Academy Drive, Gillingham, ME7 3EG	Director	01 December 2021	Active
29 Academy Drive, Gillingham, United Kingdom, ME7 3EG	Director	27 March 2014	Active

People with Significant Control

Mr Gnaneswar Vadapalli
Notified on	:	01 December 2021
Status	:	Active
Date of birth	:	August 1982
Nationality	:	British
Address	:	29 Academy Drive, Gillingham, ME7 3EG
Nature of control	:	Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors

Mrs Renuka Vadapalli
Notified on	:	06 April 2016
Status	:	Active
Date of birth	:	January 1987
Nationality	:	British
Address	:	29 Academy Drive, Gillingham, ME7 3EG
Nature of control	:	Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (2 years ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (8 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (1 year ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (10 months remaining)